Phlow Corp. Expands Analytical Capabilities and Embraces Artificial Intelligence-Driven System,Ushering in a New Era of Modern Medicine Manufacturing in America Richmond, Virginia — April 22, 2025 — Phlow Corp., a leading pharmaceutical contract development and...
2025
Phlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America
Validation Completed for a Novel, Cost-Competitive Epinephrine Active Pharmaceutical Ingredient Process, Drug Master File Successfully Filed Richmond, Virginia, March 17, 2025 -- Phlow Corp., a U.S.-based certified B Corporation on a mission to bring medicines to life...